Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
10/18/2006 | EP1711527A2 Hla-dr-specific antibodies, compositions and methods |
10/18/2006 | EP1711525A2 Neoplasm-specific polypeptides and their uses |
10/18/2006 | EP1711509A2 Inhibition of bright function as a treatment for excessive immunoglobulin production |
10/18/2006 | EP1711208A2 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
10/18/2006 | EP1711207A2 Interferon alpha antibodies and their uses |
10/18/2006 | EP1389236B1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
10/18/2006 | EP1337636B1 Soluble zcytor 11 cytokine receptors |
10/18/2006 | EP1242460B1 Immobilisation of proteins using a polypeptide segment |
10/18/2006 | EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
10/18/2006 | EP1165778B1 Uses of casb618 polynucleotides and polypeptides |
10/18/2006 | EP1141286B1 Cytokine receptor chain |
10/18/2006 | EP1131434B1 Apoptosis-inducing factor |
10/18/2006 | EP1127126B1 G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof |
10/18/2006 | EP1104479B1 Method for recovering proteins from the interstitial fluid of plant tissues |
10/18/2006 | EP1071710B1 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
10/18/2006 | EP1050584B1 Recombinant lysophosphatidic acid phosphatase |
10/18/2006 | EP1042468B1 Low-voltage activated calcium channel compositions and methods |
10/18/2006 | EP1019500B1 Ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
10/18/2006 | EP1004667B1 Cell cycle-regulating proteins |
10/18/2006 | EP0944649B1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
10/18/2006 | EP0927252B1 Antibodies against interferon alpha/beta receptor |
10/18/2006 | EP0914156B1 Passively administered antibody that enhances feed conversion efficiency |
10/18/2006 | EP0797664B1 Use of a human interleukin-11 receptor |
10/18/2006 | EP0778849B1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
10/18/2006 | CN1849400A Polynucleotides and polypeptides of the erythropoietin gene |
10/18/2006 | CN1849395A HLA-a24 binding cancer antigen peptide derived from ribin |
10/18/2006 | CN1849389A Methods for producing recombinant proteins |
10/18/2006 | CN1849339A 治疗性结合分子 Therapeutic binding molecules |
10/18/2006 | CN1849338A Antibodies against interleukin-1 receptor and uses thereof |
10/18/2006 | CN1849337A Compositions and methods for treating cancer using IGSF9 and LIV-1 |
10/18/2006 | CN1849334A Lawsonia intracellularis subunit vaccine |
10/18/2006 | CN1849144A Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ED-B |
10/18/2006 | CN1849139A Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
10/18/2006 | CN1849138A Human anti-NGF neutralizing antibodies as selective ngf pathway inhibitors |
10/18/2006 | CN1849137A Special reagent for diagnosing and treating disease based on VEFG,HER-2,PSA protein isomer |
10/18/2006 | CN1849136A Cancerous disease modifying antibodies |
10/18/2006 | CN1849135A Methods for treating interleukin-6-related diseases |
10/18/2006 | CN1847397A EHEC 0157 shiga-like toxin IIA resisting subunit monoclonal antibody 5F3 light and heavy chain variable region gene and its application |
10/18/2006 | CN1280414C Human antibody heavy chain and light chain variable region gene against SARS-Cov S antigen and polypeptide and use thereof |
10/17/2006 | USRE39350 RNA binding protein and binding site useful for expression of recombinant molecules |
10/17/2006 | US7122656 MyD88S allows activation of JNK and AP-1, whereas the NF- kappa B pathway is completely blocked; used to obtain immunosuppression (e.g., in the case of transplantation); modulation of the expression of MyD88S can regulate the cellular responses to LPS and other immunological stimuli |
10/17/2006 | US7122654 Hybrid; adjust vascular system permeability |
10/17/2006 | US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene |
10/17/2006 | US7122646 Multivalent and multispecific binding proteins, their manufacture and use |
10/17/2006 | US7122641 Methods for purifying protein |
10/17/2006 | US7122639 Chemokine alpha-2 antibodies |
10/17/2006 | US7122638 Hybridomas cell lines; viricides |
10/17/2006 | US7122637 Polypeptide variants with altered effector function |
10/17/2006 | US7122636 Antibody fragment-polymer conjugates and uses of same |
10/17/2006 | US7122635 Method and composition for angiogenesis inhibition |
10/17/2006 | US7122630 Proteins in cell cycle regulation; cell cycle protein binds to SYK kinase |
10/17/2006 | US7122629 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays |
10/17/2006 | US7122622 Somatostatin analogue as peptide and chelating group covalently linked to N-terminal free amino group of peptide, wherein analogue carries 1-naphthylalanine or 3-benzothienylalanine residue in 3-position; diagnosis |
10/17/2006 | US7122572 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation |
10/17/2006 | US7122524 Stimulating nerve growth, administering glycyl-L-phenylalanyl-L-prolineamide, N,N-diethyl-isoleucyl-phenylalanyl-L-proline ethylamide, N,N-diethyl-isoleucyl-isoleucyl-prolineamide; due to ischemic, traumatic or toxic origin |
10/17/2006 | US7122374 For immunotherapy for the treatment of diseases, e.g., neurodegenerative diseases |
10/17/2006 | US7122373 Human genes and gene expression products V |
10/17/2006 | US7122372 Peptide useful in immunomodulation |
10/17/2006 | US7122363 Comprises nucleotide sequences coding cyclic nucleotide phosphodiesterases for treatment of cardiovascular, depressive and vascular disorders; cardiotonic agents; antidepressants; antihypertensives; antithrombotics |
10/17/2006 | US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases |
10/17/2006 | US7122361 Compositions employing a novel human kinase |
10/17/2006 | US7122360 Polypeptides, polynucleotides and uses thereof |
10/17/2006 | US7122351 Dimerized PDGF-D and materials and methods for producing it |
10/17/2006 | US7122339 Method for generating diversity |
10/17/2006 | US7122336 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
10/17/2006 | US7122327 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state, and most particularly to specific biopolymer markers whose up-regulation, down-regulation, or relative presence in disease vs. normal states |
10/17/2006 | US7122324 Vitro methods for determining in vivo thrombotic events |
10/17/2006 | US7122322 Endometriosis-specific secretory protein |
10/17/2006 | US7122320 Method for detecting acid-resistant microorganisms in the stool |
10/17/2006 | US7122302 Method for determining early HCV seroconversion |
10/17/2006 | US7122197 Compounds from Moraxella catarrhalis |
10/17/2006 | US7122196 Compounds and methods for diagnosis of tuberculosis |
10/17/2006 | US7122194 Mixture of polypeptide with carrier |
10/17/2006 | US7122193 Comprising peptide analogues which have a half-life which is clearly superior to that of natural proteins or that of synthetic peptides which are or are not derived from these natural proteins |
10/17/2006 | US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody |
10/17/2006 | US7122186 For use in diagnostic, therapeutic, and industrial contexts |
10/17/2006 | US7122185 Nucleic acids; prevent humans lymphocyte virus infection; genetic engineering; transformation cells |
10/17/2006 | US7122184 Monoclonal antibody for use in prevention of fungal infections |
10/17/2006 | US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
10/17/2006 | CA2342141C Method for detection of legionella bacteria employing purified antigen-specific antibodies |
10/17/2006 | CA2195557C Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
10/17/2006 | CA2177179C Antagonists to chaperonin 10 |
10/17/2006 | CA2150497C Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
10/12/2006 | WO2006108167A1 Bioactive stents for type ii diabetics and methods for use thereof |
10/12/2006 | WO2006107708A1 Treatment of disease caused by excess free hemoglobin |
10/12/2006 | WO2006107617A2 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
10/12/2006 | WO2006107124A1 Immunoglobulin fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same |
10/12/2006 | WO2006106959A1 Anti-cd-20 monoclonal antibody |
10/12/2006 | WO2006106957A1 Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same |
10/12/2006 | WO2006106950A1 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate |
10/12/2006 | WO2006106912A1 Cancer-associated antigen analog peptide and utilization of the same |
10/12/2006 | WO2006106905A1 Process for production of polypeptide by regulation of assembly |
10/12/2006 | WO2006106903A1 sc(Fv)2 STRUCTURAL ISOMERS |
10/12/2006 | WO2006106823A1 Method for distinguishing mesenchymal stem cell using molecular marker and use thereof |
10/12/2006 | WO2006106341A2 Sheep primers |
10/12/2006 | WO2006106339A1 Pig primers |
10/12/2006 | WO2006106336A2 Rat primers |
10/12/2006 | WO2006106331A2 Mouse primers |
10/12/2006 | WO2006106323A1 Method for obtaining antibodies |
10/12/2006 | WO2006087637A3 Anti her2/neu antibody |